Summary
Updated Aug 31, 2026
Rodney Kb Young is CHIEF FINANCIAL OFFICER of RAPT Therapeutics, Inc. (RAPT). 2 SEC Form 4 filings on record going back to 2024, most recently on 5 March 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Rodney Kb Young has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Rodney Kb Young's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Paul R. Vigano - $371.84M of AVAH open-market activity in the last 12 months
- Robert M. Williams Jr. - $371.84M of AVAH open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rodney Kb Young?
Rodney Kb Young is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of RAPT Therapeutics, Inc. (RAPT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rodney Kb Young last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 2 filings going back to 2024.
Where can I see all of Rodney Kb Young's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rodney Kb Young and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial